Press Conference on Status of Cancer Research Worldwide
NEW YORK--Leading scientists from prestigious institutions around the world will convene in New York to report on the remarkable progress of their cancer research projects. Their findings will be highlighted at this press conference.
Monday, May 7, 2007
5:30pm (note: this is a new start time)
Versailles Room, St. Regis Hotel
2 East 55th Street at Fifth Avenue, New York City
"21st Century Science has Drastically Changed the Face & Pace of Cancer Research and has Started to Deliver the Cure"
Success in curing certain forms of cancer has been attained and great progress has been made in providing scientific-based drug therapies that treat many forms of cancer. The press conference and scientific review will give specific examples of breakthroughs, including one that has helped cure 50,000 people.
Listed below are a few of more than three dozen international participants:
Memorial Sloan-Kettering; Mount Sinai; Center for Cancer Research; National Institutes of Health; Johns Hopkins; The Salk Institute; GlaxoSmithKline; Shanghai Institute of Hematology; Dartmouth; Weizmann Institute - Israel; Institute of Cancer Research - London.
NOTE: The press conference segment is officially over at 6:30, but editors are invited to remain for the entire SWCRF Annual Scientific Review. The Scientific Advisory Committee will present their progress report to supporters and there will be opportunities for one-on-one and small group discussions with renowned scientists from around the world.
PLEASE RSVP TODAY!
To confirm that you will be joining us, please RSVP to Martin Maloney (m.maloney@bmcorp.com) or David Humphrey (d.humphrey@bmcorp.com), or call us at 203-661-2900.
About SWCRF
Now in its 32nd year, the Samuel Waxman Cancer Research Foundation (SWCRF) "Institute Without Walls" is a unique non-profit international organization dedicated to supporting focused concept-driven research to develop targeted cancer cell-specific therapies, such as differentiation therapy. Two drugs developed through Foundation-supported research, and now used worldwide, have proven the effectiveness of non-toxic differentiation in the treatment of acute promyelocytic leukemia (APL), which has helped cure 50,000 people.
The Foundation funds highly collaborative research groups throughout the United States, Canada, China, Europe and Israel. SWCRF grant applicants are established investigators who agree to collaborate with other SWCRF investigators on research projects funded by the Foundation. For more information, visit www.waxmancancer.org.
Contacts
Samuel Waxman Cancer Research Foundation
Martin Maloney / David Humphrey, 203-661-2900
m.maloney@bmcorp.com / d.humphrey@bmcorp.com
Monday, May 7, 2007
5:30pm (note: this is a new start time)
Versailles Room, St. Regis Hotel
2 East 55th Street at Fifth Avenue, New York City
"21st Century Science has Drastically Changed the Face & Pace of Cancer Research and has Started to Deliver the Cure"
Success in curing certain forms of cancer has been attained and great progress has been made in providing scientific-based drug therapies that treat many forms of cancer. The press conference and scientific review will give specific examples of breakthroughs, including one that has helped cure 50,000 people.
Listed below are a few of more than three dozen international participants:
Memorial Sloan-Kettering; Mount Sinai; Center for Cancer Research; National Institutes of Health; Johns Hopkins; The Salk Institute; GlaxoSmithKline; Shanghai Institute of Hematology; Dartmouth; Weizmann Institute - Israel; Institute of Cancer Research - London.
NOTE: The press conference segment is officially over at 6:30, but editors are invited to remain for the entire SWCRF Annual Scientific Review. The Scientific Advisory Committee will present their progress report to supporters and there will be opportunities for one-on-one and small group discussions with renowned scientists from around the world.
PLEASE RSVP TODAY!
To confirm that you will be joining us, please RSVP to Martin Maloney (m.maloney@bmcorp.com) or David Humphrey (d.humphrey@bmcorp.com), or call us at 203-661-2900.
About SWCRF
Now in its 32nd year, the Samuel Waxman Cancer Research Foundation (SWCRF) "Institute Without Walls" is a unique non-profit international organization dedicated to supporting focused concept-driven research to develop targeted cancer cell-specific therapies, such as differentiation therapy. Two drugs developed through Foundation-supported research, and now used worldwide, have proven the effectiveness of non-toxic differentiation in the treatment of acute promyelocytic leukemia (APL), which has helped cure 50,000 people.
The Foundation funds highly collaborative research groups throughout the United States, Canada, China, Europe and Israel. SWCRF grant applicants are established investigators who agree to collaborate with other SWCRF investigators on research projects funded by the Foundation. For more information, visit www.waxmancancer.org.
Contacts
Samuel Waxman Cancer Research Foundation
Martin Maloney / David Humphrey, 203-661-2900
m.maloney@bmcorp.com / d.humphrey@bmcorp.com
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.